APOBEC3G-independent reduction in virion infectivity during long-term HIV-1 replication in terminally differentiated macrophages
- 3 August 2008
- Vol. 379 (2) , 266-274
- https://doi.org/10.1016/j.virol.2008.06.033
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- The DNA Deaminase Activity of Human APOBEC3G Is Required for Ty1, MusD, and Human Immunodeficiency Virus Type 1 RestrictionJournal of Virology, 2008
- Enzymatically Active APOBEC3G Is Required for Efficient Inhibition of Human Immunodeficiency Virus Type 1Journal of Virology, 2007
- The Interaction of APOBEC3G with Human Immunodeficiency Virus Type 1 Nucleocapsid Inhibits tRNA 3 Lys Annealing to Viral RNAJournal of Virology, 2007
- Production of infectious virus and degradation of APOBEC3G are separable functional properties of human immunodeficiency virus type 1 VifVirology, 2007
- Human Immunodeficiency Virus Type 1 Vif Inhibits Packaging and Antiviral Activity of a Degradation-Resistant APOBEC3G VariantJournal of Virology, 2007
- Human Immunodeficiency Virus Type 1 cDNAs Produced in the Presence of APOBEC3G Exhibit Defects in Plus-Strand DNA Transfer and IntegrationJournal of Virology, 2007
- Inhibition of \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\mathrm{tRNA}_{3}^{\mathrm{Lys}}\) \end{document}-Primed Reverse Transcription by Human APOBEC3G during Human Immunodeficiency Virus Type 1 ReplicationJournal of Virology, 2006
- Antiviral Potency of APOBEC Proteins Does Not Correlate with Cytidine DeaminationJournal of Virology, 2006
- Monomeric APOBEC3G Is Catalytically Active and Has Antiviral ActivityJournal of Virology, 2006
- Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcriptsNature, 2003